HOSPIRA INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?
HOSPIRA INC has fifty-one approved drugs.
There are four tentative approvals on HOSPIRA INC drugs.
Summary for HOSPIRA INC
US Patents: | 0 |
Tradenames: | 42 |
Ingredients: | 33 |
NDAs: | 51 |
Drug Master File Entries: | 32 |
Patent Litigation for HOSPIRA INC: | See patent lawsuits for HOSPIRA INC |
Drugs and US Patents for HOSPIRA INC
Expired US Patents for HOSPIRA INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hospira Inc | NIPENT | pentostatin | INJECTABLE;INJECTION | 020122-001 | Oct 11, 1991 | 3,923,785 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.